Strides wants Malaysian unit to transform biologic economics
This article was originally published in Scrip
Executive Summary
Close on the heels of the divestment of its injectables arm, Agila Specialties, to Mylan, India's Strides Arcolab now appears to be gearing to build up its biotech business with cutting edge, cost-effective manufacturing.